STRATA Skin Sciences is a medical technology company dedicated to developing, commercializing, and marketing innovative products for the in-office treatment of various dermatologic conditions, such as ...
The February 2026 meta-analysis confirms that 308 nm Excimer Laser therapy, reliably produces significant improvement in plaque psoriasis. STRATA Skin Sciences remains committed to advancing clinical ...
STRATA Skin Sciences, Inc. SSKN recently highlighted findings from a newly published meta-analysis that reinforces the clinical efficacy of its core 308 nm excimer laser technology in treating plaque ...
STRATA Skin Sciences announces a study validating its Excimer Laser technology's superiority in treating dermatological conditions compared to traditional UVB sources. STRATA Skin Sciences, Inc.
An excimer laser's high-power ultraviolet emission enables applications in research, micromanufacturing and biomedicine. Rainer Paetzel and Ruediger Hack provide an introduction to the technology and ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Elios procedure uses an excimer laser to open the ...
Aug. 17, 2004 — Therapy with the 308-nm excimer laser is a safe and effective method of correcting hypopigmentation in scars and striae alba, according to the results of a randomized controlled trial ...
Please provide your email address to receive an email when new articles are posted on . To celebrate the 40th anniversary of Healio/Ocular Surgery News, we are looking back at major developments in ...
The EX350 from GAM Laser Inc. offers up to 20 W average power at 248 nm when running at 100 Hz, this laser is the system of choice to provide high energy and high performance in a compact and low cost ...
When patients mention 'laser angioplasty,' they often envision a rapid and painless fix. Yet, cardiologists explain that the ...
Both the excimer laser and the pulsed-dye laser (PDL) effectively treat psoriasis, but which is more effective? In this self-controlled, prospective trial sponsored by the manufacturer of the PDL, 22 ...